Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5129322 | 6142540 | F | 1 | 5129322-6 | 20060913 | 20060928 | 20061011 | EXP | 009-C5013-06090695 | CELGENE CORPORATION | 50 | YR | F | N | 44 | KG | 20060928 | MD | 20060915 | AUSTRIA |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5129322 | 1007765939 | PS | REVLIMID | 1 | ORAL | 5 MG, 1 IN 2 D, ORAL | D | D | 21880 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5129322 | 1007765939 | MULTIPLE MYELOMA |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5129322 | DE |
| 5129322 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 5129322 | BLOOD CREATINE INCREASED |
| 5129322 | CARDIAC FAILURE |
| 5129322 | EPISTAXIS |
| 5129322 | FEBRILE NEUTROPENIA |
| 5129322 | HAEMOGLOBIN DECREASED |
| 5129322 | INFECTION |
| 5129322 | MOUTH HAEMORRHAGE |
| 5129322 | MUCOSAL HAEMORRHAGE |
| 5129322 | PAIN |
| 5129322 | SEPSIS |
| 5129322 | THROMBOCYTOPENIA |
| 5129322 | WHITE BLOOD CELL COUNT DECREASED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 5129322 | FGN |
| 5129322 | HP |
| 5129322 | SDY |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5129322 | 1007765939 | 20060816 | 20060830 | ||
| 5129322 | 1007765939 | 20060830 | 20060908 |